Tricyclic heteroaromatic compounds as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
Details for Australian Patent Application No. 2007319952 (hide)
International Classifications
Event Publications
28 May 2009 PCT application entered the National Phase
PCT publication WO2008/060488 Priority application(s): WO2008/060488
21 January 2010 Alteration of Name
The name of the applicant has been altered to Merck Sharp & Dohme Corp.
26 April 2012 Application Accepted
Published as AU-B-2007319952
23 August 2012 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2007319975-Photonic crystal sensors with integrated fluid containment structure
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser